[Question] gradient — what am I missing here
Asking properly rather than in a comment on somebody else’s thread: gradient — what am I missing here. A shoulder that does not baseline-resolve cannot be quantified honestly. You can report it as an unresolved shoulder, which is useful information, or you can develop the method until it resolves. Chased a ghost peak…
This. A shoulder that does not baseline-resolve is a question, not a quantity.
Disagree. Inter-lab spread of a point or two on this assay is ordinary and calling it a discrepancy misleads people.
integration decisions move the number more than the sample does
Gave the same trace to two people I trust and got two integrations about a point apart. That was the most educational afternoon I have had here.
System suitability — repeat injections, tailing factor, plate count, RSD on area — is what tells you the instrument was fit for the measurement that day. Without it, the purity figure is unanchored.
214nm sees the peptide bond, 280nm sees the aromatics
Same method at both labs, or two different gradients?
Push back: a longer run is not automatically better resolution. You are trading peak width for time and the ratio is what matters.
Started reporting my own integrations with the baseline choice stated. Arguments in my threads dropped by about half.
Agreed. Two analysts, one trace, two integration choices, and a spread that has nothing to do with the vial.
Yes. Retention time is a hypothesis about identity. Mass is the answer.